GLP-1 (glucagon-like peptide-1 receptor agonists) medications have become one of the most talked-about, and most challenging, topics in employer-sponsored health plans. What began as a treatment for ...

GLP-1 medications have officially crossed from trending to expected in the workplace, according to 9amHealth's new consumer ...

Drugmaker Eli Lilly is rolling out a new model to make it easier for employers to provide access to its GLP-1 drugs for weight management. Lilly said in an announcement that the model is built on ...

Eli Lilly has launched Employer Connect, a platform that offers employers a direct route to offer Zepbound coverage to workers at a list price of $449 per month, bypassing traditional pharmacy ...

As demand for GLP-1s skyrockets, employers are struggling with the cost to cover these expensive medications for their employees. That’s why the Peterson Health Technology Institute, an independent ...

Rising prescription drug costs are top of mind for employers, and GLP-1s are partly responsible. The drugs — while proven highly effective — come at a hefty price tag, leading to many employers having ...

Andel consolidates employer demand and buys directly from manufacturers at cash prices. Employers set their own contribution. Workers pay the rest — typically less than other cash channels, CEO Jay ...

Once niche treatments, GLP-1 drugs — originally developed for diabetes and now widely prescribed for weight management — have seen explosive growth in adoption rates, sparking intense discussion ...